353
Participants
Start Date
June 30, 2011
Primary Completion Date
July 31, 2014
Study Completion Date
July 31, 2014
Levetiracetam
250 mg and 500 mg Levetiracetam tablet, 1000 mg-3000 mg/day, maximum 50 weeks including initial up titration of 500 mg/day for 2 weeks
Oxcarbazepine
150 mg and 300 mg Oxcarbazepine tablet, 900 mg-2400 mg/day, maximum 50 weeks including 2 weeks of up titration (300 mg/day 1week then 600 mg/day 1 week)
05, Busan
10, Busan
16, Busan
06, Daejeon
18, Daejeon
23, Gangwon-Do
08, Goyang-si
09, Goyang-si
07, Gwangju
22, Junggu
14, Seongnam-si
01, Seoul
02, Seoul
03, Seoul
04, Seoul
11, Seoul
12, Seoul
13, Seoul
15, Seoul
17, Seoul
20, Seoul
21, Seoul
19, Ulsan
Korea UCB Co., Ltd.
INDUSTRY